Peroxiredoxin I deficiency increases keratinocyte apoptosis in a skin tumor model via the ROS-p38 MAPK pathway.

MLA

Han, Ying-Hao, et al. “Peroxiredoxin I Deficiency Increases Keratinocyte Apoptosis in a Skin Tumor Model via the ROS-P38 MAPK Pathway.” Biochemical & Biophysical Research Communications, vol. 529, no. 3, Aug. 2020, pp. 635–41. EBSCOhost, https://doi.org/10.1016/j.bbrc.2020.06.047.

APA

Han, Y.-H., Zhang, Y.-Q., Jin, M.-H., Jin, Y.-H., Qiu, M.-Y., Li, W.-L., He, C., Yu, L.-Y., Hyun, J. W., Lee, J., Yoon, D.-Y., Sun, H.-N., & Kwon, T. (2020). Peroxiredoxin I deficiency increases keratinocyte apoptosis in a skin tumor model via the ROS-p38 MAPK pathway. Biochemical & Biophysical Research Communications, 529(3), 635–641. https://doi.org/10.1016/j.bbrc.2020.06.047

Chicago

Han, Ying-Hao, Yong-Qing Zhang, Mei-Hua Jin, Ying-Hua Jin, Mei-Yu Qiu, Wei-Long Li, Chao He, et al. 2020. “Peroxiredoxin I Deficiency Increases Keratinocyte Apoptosis in a Skin Tumor Model via the ROS-P38 MAPK Pathway.” Biochemical & Biophysical Research Communications 529 (3): 635–41. doi:10.1016/j.bbrc.2020.06.047.